Back to company

VarCT Diagnostics ApS: Financial statements 2019

CVR: 38733567

VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -2,020,592 and a net result of DKK -3,221,331 compared with DKK -1,767,180 the year before. Equity amounted to DKK 9,503,072. The solvency ratio was 79.2%. The company had 3 employees in the financial year.

Gross Profit
-2,020,592 kr.
Profit/Loss
-3,221,331 kr.
Equity
9,503,072 kr.
Total Assets
12,003,853 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--2 mio.-3.2 mio.9.5 mio.3
2018--472 t.-1.8 mio.12.7 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

VarCT Diagnostics ApS: The 2018 annual report is outMay 23, 2019

VarCT Diagnostics ApS has published its annual report for 2018. Gross profit came to DKK -472,235, and the net result was DKK -1,767,180.

About VarCT Diagnostics ApS

VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees. In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity amounted to DKK 2,238,264.

Other financial years